Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Other Non-Current Assets (2016 - 2025)

AC Immune (ACIU) has disclosed Other Non-Current Assets for 9 consecutive years, with $473731.6 as the latest value for Q4 2024.

  • On a quarterly basis, Other Non-Current Assets rose 16.4% to $473731.6 in Q4 2024 year-over-year; TTM through Dec 2024 was $473731.6, a 16.4% increase, with the full-year FY2024 number at $473731.6, up 17.86% from a year prior.
  • Other Non-Current Assets was $473731.6 for Q4 2024 at AC Immune, up from $406975.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $473731.6 in Q4 2024 to a low of $369456.0 in Q4 2020.
  • A 5-year average of $403712.5 and a median of $393674.3 in 2021 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: increased 20.28% in 2020, then dropped 4.81% in 2022.
  • AC Immune's Other Non-Current Assets stood at $369456.0 in 2020, then rose by 6.56% to $393674.3 in 2021, then decreased by 4.81% to $374725.9 in 2022, then increased by 8.61% to $406975.0 in 2023, then grew by 16.4% to $473731.6 in 2024.
  • Per Business Quant, the three most recent readings for ACIU's Other Non-Current Assets are $473731.6 (Q4 2024), $406975.0 (Q4 2023), and $374725.9 (Q4 2022).